Evidence map›Paper›PMID 28058468›Full record

ReviewDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2017

[Nonviral sexually transmitted infections-epidemiology, clinical manifestations, diagnostic workup, therapy : Part 3: Treponemes, Gardnerella and trichomonads].

P Nenoff, A Manos, I Ehrhard, C Krüger, U Paasch, P Helmbold, W Handrick

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

P NenoffPartnerschaft Prof. Dr. med. Pietro Nenoff & Dr. med. Constanze Krüger, Labor für medizinische Mikrobiologie, Mölbiser Hauptstr. 8, 04571, Rötha/OT Mölbis, Deutschland. nenoff@mykologie-experten.de.
A ManosBeratungsstelle für sexuell übertragbare Krankheiten und AIDS, Gesundheitsamt Leipzig, Leipzig, Deutschland.
I EhrhardAbt. Medizinische Mikrobiologie und Hygiene, Landesuntersuchungsanstalt für das Gesundheits- und Veterinärwesen Sachsen, Dresden, Deutschland.
C KrügerPartnerschaft Prof. Dr. med. Pietro Nenoff & Dr. med. Constanze Krüger, Labor für medizinische Mikrobiologie, Mölbiser Hauptstr. 8, 04571, Rötha/OT Mölbis, Deutschland.
U PaaschKlinik und Poliklinik für Dermatologie, Venerologie und Allergologie, Universität Leipzig, Leipzig, Deutschland.
P HelmboldHautklinik des Klinikums der Universität Heidelberg, Heidelberg, Deutschland.
W HandrickInstitut für Medizinische Diagnostik Oderland, Frankfurt (Oder), Deutschland.
Gesundheitsamt · DEHautklinik Heidelberg · DELandesuntersuchungsanstalt Sachsen · DELeipzig University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Germany, the reported syphilis prevalence has increased continuously since 2010, with a total of 6834 syphilis cases being reported in 2015. The largest increase of reported syphilis occurred in men who have sex with men (MSM). The antibiotic agent of choice for treatment of syphilis is still penicillin. There are no penicillin-resistant Treponema pallidum strains. Alternatives are ceftriaxone and doxycycline. In Germany, azithromycin is not approved for treatment of syphilis; however, therapy failures are increasingly reported. Bacterial vaginosis is accompanied by vaginal discharge. The vaginal secretion exhibits an increased pH value higher than 4.5. Clinical symptoms are pruritus, burning, and the characteristic amine odor. The probability for bacterial vaginosis is highest in women with higher numbers of sexual partners, unmarried women, early first sexual intercourse, in commercial female sex workers, and those women who regularly apply vaginal douches. The main pathogen of bacterial vaginosis is Gardnerella vaginalis. For oral therapy metronidazole is given, alternatively clindamycin; the latter should be applied additionally as topical agent. Trichomoniasis is considered as the nonviral sexually transmitted infection with the highest prevalence worldwide. Other than direct microscopic detection of the protozoa (trophozoites) in vaginal secretion or urine, PCR has been approved as the diagnostic method with the highest sensitivity. Oral metronidazole represents the therapy of choice in trichomoniasis.

Indexed as

Anti-Bacterial AgentsAntiprotozoal AgentsEvidence-Based MedicineFemaleGermanyHumansMalePrevalenceRisk FactorsSexually Transmitted DiseasesSymptom AssessmentTreatment OutcomeTreponemal InfectionsTrichomonas InfectionsVaginosis, BacterialAnti-Bacterial AgentsAntiprotozoal AgentsBacterial vaginosisGardnerella vaginalisSyphilisTreponema pallidumTrichomonas vaginalis

Identifiers

PMID28058468
OpenAlexW2568834652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.